This
page lists clinical trials for treating West Nile virus
disease as a service to medical providers and the public
and does not imply CDC endorsement of the entity conducting
the study or the drug under investigation. The order
of the studies below reflects the timing of their admission
to the list only. To gain more information about any
of these clinical trials, follow the website link associated
with the study description.
Studies included on the list
below must meet the following ethical and scientific
criteria:
Institutional
Review Board (IRB) approved
Randomized
Double-blinded
Placebo-controlled
The
following study has met these criteria:
1)
A Randomized Double-Blinded, Placebo Controlled
Trial of Alpha-Interferon (Alferon) Therapy for West
Nile Meningoencephalitis (Protocol WN-102).
Contact: James J. Rahal, MD, Tel. (718)-670-1525, email:
JJR9002@nyp.org
Website: http://www.nyhq.org/posting/rahal.html
To submit information about additional clinical trials
for possible inclusion on this page, please contact CDC's
Division of Vector-Borne Infectious Diseases at (970) 221-6400.
|